Free Trial

Accelerate Diagnostics (AXDX) Short Interest Ratio & Short Volume

Accelerate Diagnostics logo
$1.63 -0.07 (-4.12%)
(As of 10:17 AM ET)

Accelerate Diagnostics Short Interest Data

Accelerate Diagnostics (AXDX) has a short interest of 510,500 shares, representing 3.48% of the float (the number of shares available for trading by the public). This marks a 7.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.6, indicating that it would take 7.6 days of the average trading volume of 81,564 shares to cover all short positions.

Current Short Interest
510,500 shares
Previous Short Interest
473,100 shares
Change Vs. Previous Month
+7.91%
Dollar Volume Sold Short
$980,160.00
Short Interest Ratio
7.6 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
25,040,000 shares
Float Size
14,660,000 shares
Short Percent of Float
3.48%
Today's Trading Volume
1,761 shares
Average Trading Volume
81,564 shares
Today's Volume Vs. Average
2%
Short Selling Accelerate Diagnostics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Accelerate Diagnostics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AXDX Short Interest Over Time

AXDX Days to Cover Over Time

AXDX Percentage of Float Shorted Over Time

Accelerate Diagnostics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024510,500 shares $980,160.00 +7.9%3.5%7.6 $1.92
10/15/2024473,100 shares $884,697.00 -0.8%3.4%7.7 $1.87
9/30/2024476,700 shares $815,157.00 +1.8%3.4%8.3 $1.71
9/15/2024468,400 shares $711,968.00 -12.6%3.4%8.9 $1.52
8/31/2024535,700 shares $1.07 million -2.8%3.9%10 $2.00
8/15/2024551,100 shares $920,337.00 -8.0%4.2%8.4 $1.67
7/31/2024599,300 shares $809,055.00 -1.4%4.9%8.7 $1.35
7/15/2024607,700 shares $698,855.00 -3.4%5.0%9.1 $1.15
6/30/2024629,000 shares $735,930.00 +14.0%5.2%9.1 $1.17
6/15/2024551,700 shares $744,795.00 +30.0%4.5%7.1 $1.35
5/31/2024424,400 shares $505,036.00 +9.6%3.5%5.6 $1.19
5/15/2024387,300 shares $356,316.00 +19.9%2.8%5.3 $0.92
4/30/2024322,900 shares $284,668.64 -13.6%2.5%5.2 $0.88
4/15/2024373,700 shares $326,987.50 +27.7%2.9%4.3 $0.88
3/31/2024292,600 shares $289,674.00 +1.7%2.3%2.2 $0.99
3/15/2024287,600 shares $273,220.00 -3.8%2.4%2.4 $0.95
2/29/2024299,000 shares $294,544.90 -13.9%2.5%2.5 $0.99
2/15/2024347,300 shares $413,287.00 -7.2%2.9%3 $1.19
1/31/2024374,200 shares $497,686.00 -16.5%4.2%3.4 $1.33
1/15/2024448,300 shares $1.66 million +9.9%5.8%5.3 $3.70
12/31/2023407,800 shares $1.60 million +3.6%5.3%14.1 $3.92
12/15/2023393,500 shares $1.81 million -10.0%5.1%13.9 $4.61
11/30/2023437,300 shares $1.89 million +11.9%5.8%17.6 $4.32
11/15/2023390,900 shares $2.07 million -2.4%5.2%23.1 $5.29
10/31/2023400,500 shares $2.40 million +11.8%5.4%23 $5.99
10/15/2023358,100 shares $2.11 million +11.5%4.8%17.9 $5.88
9/30/2023321,300 shares $1.85 million -8.9%4.3%13 $5.75
9/15/2023352,600 shares $2.16 million -15.2%4.7%15.3 $6.14
8/31/2023415,800 shares $2.91 million -1.2%9.3%15.6 $7.01
8/15/2023420,900 shares $2.98 million -3.8%9.4%15.1 $7.09
7/31/2023437,400 shares $2.91 million +8.4%14.1%15.9 $6.66
7/15/2023403,500 shares $2.80 million +3.5%13.0%14.6 $6.95
6/30/2023390,000 shares $3.16 million -90.3%12.5%16.3 $8.10
6/15/20234,000,000 shares $3.17 million -7.6%12.9%14.9 $0.79
5/31/20234,330,000 shares $3.03 million +6.7%N/A16.7 $0.70
5/15/20234,060,000 shares $3.25 million -6.0%N/A13.4 $0.80
4/30/20234,320,000 shares $3.81 million -11.1%N/A14 $0.88
4/15/20234,860,000 shares $3.21 million +2.1%N/A16 $0.66
3/31/20234,760,000 shares $3.33 million -6.1%N/A16.2 $0.70
3/15/20235,070,000 shares $2.74 million +7.2%N/A16.6 $0.54
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

2/28/20234,730,000 shares $2.41 million +5.1%N/A15 $0.51
2/15/20234,500,000 shares $2.70 million +0.5%N/A15.5 $0.60
1/31/20234,480,000 shares $3.11 million +0.5%N/A15.8 $0.69
1/15/20234,460,000 shares $3.21 million -0.7%N/A13.3 $0.72
12/30/20224,490,000 shares $3.17 million +3.7%N/A13.6 $0.71
12/15/20224,330,000 shares $2.94 million -0.2%N/A14.6 $0.68
11/30/20224,340,000 shares $3.77 million +10.7%N/A12.8 $0.87
11/15/20223,920,000 shares $4.78 million -1.3%N/A8.4 $1.22
10/31/20223,970,000 shares $5.04 million -17.6%N/A4.3 $1.27
10/15/20224,820,000 shares $7.42 million -1.8%N/A5.1 $1.54
9/30/20224,910,000 shares $7.46 million -3.0%N/A5.3 $1.52
9/15/20225,060,000 shares $8.30 million -1.8%N/A4.6 $1.64
8/31/20225,150,000 shares $8.39 million -8.9%N/A4.1 $1.63
8/15/20225,650,000 shares $15.14 million +4.4%N/A3.9 $2.68
7/31/20225,410,000 shares $7.25 million +5.3%10.6%5.2 $1.34
7/15/20225,140,000 shares $7.30 million +5.3%10.1%4.7 $1.42
6/30/20224,880,000 shares $4.84 million -27.5%9.6%4.3 $0.99
6/15/20226,730,000 shares $6.25 million -3.4%13.2%5.9 $0.93
5/31/20226,970,000 shares $4.24 million +3.6%13.6%7.7 $0.61
5/15/20226,730,000 shares $4.64 million +0.3%14.3%12.7 $0.69
4/30/20226,710,000 shares $6.44 million -5.0%16.2%14.6 $0.96
4/15/20227,060,000 shares $7.27 million No Change17.0%17.1 $1.03
3/31/20227,060,000 shares $10.17 million +1.3%17.0%19.8 $1.44
3/15/20226,970,000 shares $11.85 million +1.5%17.3%22 $1.70
2/28/20226,870,000 shares $19.51 million -3.8%16.6%20.6 $2.84
2/15/20227,140,000 shares $20.13 million +2.0%17.3%18.7 $2.82
1/31/20227,000,000 shares $23.31 million +6.7%17.7%16.2 $3.33
1/15/20226,560,000 shares $26.90 million -1.4%16.5%15.7 $4.10
12/31/20216,650,000 shares $34.71 million -4.6%17.6%15.5 $5.22
12/15/20216,970,000 shares $31.64 million -2.7%18.5%15.2 $4.54
11/30/20217,160,000 shares $35.80 million -0.1%19.8%18 $5.00
11/15/20217,170,000 shares $47.97 million No Change19.1%21.8 $6.69
10/29/20217,170,000 shares $42.30 million -4.5%20.4%26.2 $5.90
10/15/20217,510,000 shares $49.79 million +0.8%21.4%29.8 $6.63
9/30/20217,450,000 shares $43.43 million -3.4%21.2%36.2 $5.83
9/15/20217,710,000 shares $46.11 million -2.4%22.5%49.5 $5.98
8/31/20217,900,000 shares $49.38 million -2.0%23.2%49.9 $6.25
8/13/20218,060,000 shares $48.12 million +0.1%23.6%47.6 $5.97
7/30/20218,050,000 shares $60.05 million +2.7%23.8%47.7 $7.46
7/15/20217,840,000 shares $51.35 million +0.9%23.2%42.7 $6.55
6/30/20217,770,000 shares $62.63 million -2.0%23.0%41.2 $8.06
6/15/20217,930,000 shares $71.29 million -3.7%23.4%41.4 $8.99
5/28/20218,230,000 shares $62.47 million +3.4%24.2%41.3 $7.59
5/14/20217,960,000 shares $54.21 million -8.2%23.4%35 $6.81
4/30/20218,670,000 shares $64.24 million -0.2%25.4%33.9 $7.41
4/15/20218,690,000 shares $70.22 million -1.1%25.4%15.8 $8.08
3/31/20218,790,000 shares $71.46 million -0.8%26.7%15.4 $8.13
3/15/20218,860,000 shares $79.65 million +1.0%27.8%14.9 $8.99
2/26/20218,770,000 shares $90.24 million -8.5%27.5%14.4 $10.29
2/12/20219,580,000 shares $139.01 million -10.6%30.0%15.7 $14.51
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

1/29/202110,710,000 shares $110.63 million -19.9%34.8%18.1 $10.33
1/15/202113,370,000 shares $117.39 million -2.8%44.9%30.8 $8.78
12/31/202013,760,000 shares $102.51 million +0.2%46.3%52 $7.45
12/15/202013,740,000 shares $99.75 million -4.5%46.2%55.2 $7.26
11/30/202014,380,000 shares $116.77 million -3.4%48.3%56.4 $8.12
11/15/202014,880,000 shares $127.82 million -4.2%50.6%62 $8.59
10/30/202015,530,000 shares $147.22 million -0.6%52.8%57.8 $9.48
10/15/202015,630,000 shares $178.65 million -0.3%53.8%53.9 $11.43
9/30/202015,670,000 shares $167.04 million +5.0%53.9%49.3 $10.66
9/15/202014,920,000 shares $160.69 million +0.5%51.3%37.1 $10.77
8/31/202014,850,000 shares $180.87 million -3.3%51.1%31.5 $12.18
8/14/202015,350,000 shares $222.73 million -2.4%53.8%31.7 $14.51
7/31/202015,720,000 shares $228.41 million -0.3%55.1%34 $14.53
7/15/202015,760,000 shares $275.80 million -8.9%56.3%31.7 $17.50
6/30/202017,300,000 shares $249.99 million +1.7%61.8%33.8 $14.45
6/15/202017,010,000 shares $171.80 million +1.5%60.8%35.2 $10.10
5/29/202016,760,000 shares $140.78 million -0.3%55.1%34.6 $8.40
5/15/202016,810,000 shares $148.18 million +1.0%55.2%35.5 $8.82
4/30/202016,640,000 shares $181.54 million +5.5%52.9%37.2 $10.91
4/15/202015,780,000 shares $131.92 million +2.8%51.0%40.1 $8.36
3/31/202015,350,000 shares $157.80 million -0.6%51.4%41.9 $10.28
3/13/202015,443,500 shares $142.85 million +0.6%52.2%46.1 $9.25
2/28/202015,350,000 shares $91.03 million -0.8%51.9%68.3 $5.93
2/14/202015,470,000 shares $168.00 million -0.1%52.4%76.7 $10.86
1/31/202015,490,000 shares $221.82 million -1.9%52.5%74.8 $14.32
1/15/202015,790,000 shares $263.06 million -2.8%53.5%75.4 $16.66
12/31/201916,250,000 shares $266.66 million -0.7%55.1%88.8 $16.41

AXDX Short Interest - Frequently Asked Questions

What is Accelerate Diagnostics' current short interest?

Short interest is the volume of Accelerate Diagnostics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 510,500 shares of AXDX short. 3.48% of Accelerate Diagnostics' shares are currently sold short. Learn More on Accelerate Diagnostics' current short interest.

What is a good short interest ratio for Accelerate Diagnostics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXDX shares currently have a short interest ratio of 8.0. Learn More on Accelerate Diagnostics's short interest ratio.

Which institutional investors are shorting Accelerate Diagnostics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Accelerate Diagnostics: Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Accelerate Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.48% of Accelerate Diagnostics' floating shares are currently sold short.

Is Accelerate Diagnostics' short interest increasing or decreasing?

Accelerate Diagnostics saw a increase in short interest in October. As of October 31st, there was short interest totaling 510,500 shares, an increase of 7.9% from the previous total of 473,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Accelerate Diagnostics' float size?

Accelerate Diagnostics currently has issued a total of 25,044,000 shares. Some of Accelerate Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Accelerate Diagnostics currently has a public float of 14,660,000 shares.

How does Accelerate Diagnostics' short interest compare to its competitors?

3.48% of Accelerate Diagnostics' shares are currently sold short. Here is how the short interest of companies compare to Accelerate Diagnostics: Harvard Bioscience, Inc. (0.91%), Seer, Inc. (2.34%), Frequency Electronics, Inc. (0.29%), Kewaunee Scientific Co. (1.94%), Akoya Biosciences, Inc. (7.80%), 908 Devices Inc. (5.69%), Owlet, Inc. (3.70%), Optex Systems Holdings, Inc (0.19%), Singular Genomics Systems, Inc. (4.81%), MultiSensor AI Holdings, Inc. (0.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Accelerate Diagnostics stock?

Short selling AXDX is an investing strategy that aims to generate trading profit from Accelerate Diagnostics as its price is falling. AXDX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Accelerate Diagnostics?

A short squeeze for Accelerate Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXDX, which in turn drives the price of the stock up even further.

How often is Accelerate Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXDX, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:AXDX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners